Single-Segment Structure Focused on the Diagnostic Reagent Business
First written in FY2016. 20 of 21 entries say "Restated". Latest entry: FY2024-Q1.
1 other company's latest entry also says "Restated".
- FY2024-Q1RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The business structure consisting solely of the diagnostic reagent business as a single segment continues. - FY2023-Q3RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The business structure consisting solely of the diagnostic reagent business as a single segment continues. - FY2023-Q2RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The business structure consisting solely of the diagnostic reagent business as a single segment continues. - FY2023-Q1RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The business structure consisting solely of the diagnostic reagent business as a single segment continues. - FY2022RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The Group continues to operate with a single-segment structure consisting solely of the diagnostic reagent business. - FY2022-Q3RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The business structure consisting solely of the diagnostic reagent business as a single segment continues. - FY2020RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The Group continues to operate with a single-segment structure consisting solely of the diagnostic reagent business. - FY2020-Q2RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The business structure consisting solely of the diagnostic reagent business as a single segment continues. - FY2020-Q1RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The business structure consisting solely of the diagnostic reagent business as a single segment continues. - FY2019-Q3RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The structure consisting solely of the diagnostic reagent business as a single segment continues to be described. - FY2019-Q2RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The structure consisting solely of the diagnostic reagent business as a single segment continues to be described. - FY2019-Q1RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The Group continues to operate with a single-segment structure consisting solely of the diagnostic reagent business. - FY2018RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The Group continues to operate with a single-segment structure consisting solely of the diagnostic reagent business. - FY2018-Q3RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The structure consisting solely of the diagnostic reagent business as a single segment continues to be described. - FY2018-Q2RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The structure consisting solely of the diagnostic reagent business as a single segment continues to be described. - FY2018-Q1RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
There have been no material changes to the single-segment structure consisting solely of the diagnostic reagent business. - FY2017RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The Group continues to operate with a single-segment structure consisting solely of the diagnostic reagent business. - FY2017-Q3RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The structure consisting solely of the diagnostic reagent business as a single segment continues to be described. - FY2017-Q2RestatedAnnual report
「As the Group consists solely of a single segment, the diagnostic reagent business, the description has been omitted.」
The structure consisting solely of the diagnostic reagent business as a single segment continues to be described. - FY2017-Q1RestatedAnnual report
「There were no material changes in the businesses conducted by the Group (the Company and its affiliates) during the first quarter of the current consolidated fiscal year. There were also no changes among its affiliates.」
The business structure centered on the diagnostic reagent business is described as having undergone no material changes. - FY2016First statedAnnual report
「The Group consists solely of a single segment, the diagnostic reagent business, and does not distinguish between business divisions or other units.」
The Group's main business is the manufacture and sale of diagnostic reagents, while its consolidated subsidiary conducts processing, contract manufacturing, procurement and sales in China.